Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere

Ahmed Idriss Jajere; Isah Muhammad Liyo; Dembo Emmanuel Moses

doi:doi:10.11648/j.ijhpebs.20230901.16

| Peer-Reviewed

Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere

Ahmed Idriss Jajere, Isah Muhammad Liyo, Dembo Emmanuel Moses

Published in International Journal of HIV/AIDS Prevention, Education and Behavioural Science (Volume 9, Issue 1)

Received: 13 April 2023 Accepted: 28 April 2023 Published: 27 June 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

HIV/AIDS, also known as acquired immunodeficiency syndrome and human immunodeficiency virus infection, continue to be a global public health concern. A total of 150 pregnant patients at the PHCC clinic had their blood tested for the presence of HIV 1/2 antibodies. The DetermineTM HIV-1/2 in vitro diagnostic kit was used for the detection of human immunodeficiency virus antibodies (HIV). Using a pipette with arrows pointing in their direction and dropping the plasma samples onto the test strips, the reaction was allowed to occur for 15 minutes. Negative samples only display a color band in the control zone, while positive samples produce a red color band in both the test and control portions of the strips. The results showed that only 1 (0.7%) pregnant woman of the 150 tested positive for HIV. On the age group distribution of pregnant women tested for HIV in PHCC Jajere, it showed that 0 (0.0%) women aged 10–20 tested positive for HIV, 1 (0.7%) of those aged 21–30 were tested positive, 0 (0.0%) of those aged 31–40 were tested positive, and 0 (0.0%) of those aged 41–50 were tested positive for HIV. Whereas, the distribution of pregnant women tested positive for HIV in PHCC Jajere based on their locations showed that only 1 (0.7%) pregnant woman from Ganji was tested positive for HIV. It's therefore concluded that the sero-prevalence of HIV 1/2 in the study area is low, and thus, screening pregnant women for HIV/AIDS is recommended despite the low prevalence.

Published in	International Journal of HIV/AIDS Prevention, Education and Behavioural Science (Volume 9, Issue 1)
DOI	10.11648/j.ijhpebs.20230901.16
Page(s)	35-38
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Sero-Prevalence, HIV, Antibodies, PHCC Jajere

References

[1]	HIV/AIDS Factsheet". World Health Organization. Retrieved 6 March 2022.
[2]	"Why the HIV epidemic is not over". www.who.int. Retrieved 11 March 2022.
[3]	Eisinger RW, Fauci AS (March 2018). "Ending the HIV/AIDS Pandem.
[4]	ic1". Emerging Infectious Diseases. 24 (3): 413–416. doi: 10.3201/eid2403.171797. PMC 5823353. PMID 29460740.
[5]	"HIV data and statistics". www.who.int. Retrieved 21 November 2022.^ "UN AIDS DATA2019".
[6]	UNAIDS.org. 2019. Retrieved 5 December 2019.
[7]	"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015". The Lancet. HIV. 3 (8): e361–e387. August 2016. doi: 10.1016/s2352-3018(16)30087-x. PMC 5056319. PMID 27470028.
[8]	"Foreword – AIDS 2020". UNAIDS. Retrieved 6 March 2022.^ a b c d.
[9]	"Fact Sheet - WorldAidsDay 2021" (PDF). UNAIDS. 1 December 2021. Retrieved 7 March 2022.
[10]	"HIV/AIDS". WHO \| Regional Office for Africa. Retrieved 27 November 2022.
[11]	"Fact Sheet" (PDF). UNAIDS.org. 2018. Retrieved 12 December 2019.
[12]	"HIV/AIDS – adult prevalence rate - The World Factbook". www.cia.gov. Retrieved 6 March 2022.
[13]	"UNAIDS World Aids Day Report" (PDF). publisher. 2011. Archived from the original (PDF) on 29 March 2019. Retrieved 12 March 2014. The ranges define the boundaries within which the actual numbers lie, based on the best available information.
[14]	"Full report — In Danger: UNAIDS Global AIDS Update 2022". www.unaids.org. Retrieved 30 November 2022.
[15]	Eze J. I. University of Glasgow; 2009. Modeling HIV/AIDS Epidemic in Nigeria. (Ph.D. thesis) Available: < http://theses.gla.ac.uk/642/1/2009EzePhD.pdf> (accessed 6 February 2013) [Google Scholar].
[16]	Nigeria National Agency for the Control of AIDS. GARPR; Abuja, Nigeria: 2012. Global AIDS Response: Country Progress Report.
[17]	World Bank Policy Research Working Papers. 2014. Son Preference, Fertility and Family Structure: Evidence from Reproductive Behaviour Among Nigerian Women. [Google Scholar].
[18]	Sabina Khanam (2019) Prevalence of Hiv Infection Among Pregnant Women Attending Ajiko Medical Clinic, Damaturu, Nigeria. Journal of Clinical Research In HIV AIDS And Prevention – 3 (4): 7-9.

Cite This Article

Plain Text BibTeX RIS

APA Style

Ahmed Idriss Jajere, Isah Muhammad Liyo, Dembo Emmanuel Moses. (2023). Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. International Journal of HIV/AIDS Prevention, Education and Behavioural Science, 9(1), 35-38. https://doi.org/10.11648/j.ijhpebs.20230901.16

Copy | Download

ACS Style

Ahmed Idriss Jajere; Isah Muhammad Liyo; Dembo Emmanuel Moses. Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. Int. J. HIV/AIDS Prev. Educ. Behav. Sci. 2023, 9(1), 35-38. doi: 10.11648/j.ijhpebs.20230901.16

Copy | Download

AMA Style

Ahmed Idriss Jajere, Isah Muhammad Liyo, Dembo Emmanuel Moses. Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. Int J HIV/AIDS Prev Educ Behav Sci. 2023;9(1):35-38. doi: 10.11648/j.ijhpebs.20230901.16

Copy | Download

@article{10.11648/j.ijhpebs.20230901.16,
  author = {Ahmed Idriss Jajere and Isah Muhammad Liyo and Dembo Emmanuel Moses},
  title = {Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere},
  journal = {International Journal of HIV/AIDS Prevention, Education and Behavioural Science},
  volume = {9},
  number = {1},
  pages = {35-38},
  doi = {10.11648/j.ijhpebs.20230901.16},
  url = {https://doi.org/10.11648/j.ijhpebs.20230901.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijhpebs.20230901.16},
  abstract = {HIV/AIDS, also known as acquired immunodeficiency syndrome and human immunodeficiency virus infection, continue to be a global public health concern. A total of 150 pregnant patients at the PHCC clinic had their blood tested for the presence of HIV 1/2 antibodies. The DetermineTM HIV-1/2 in vitro diagnostic kit was used for the detection of human immunodeficiency virus antibodies (HIV). Using a pipette with arrows pointing in their direction and dropping the plasma samples onto the test strips, the reaction was allowed to occur for 15 minutes. Negative samples only display a color band in the control zone, while positive samples produce a red color band in both the test and control portions of the strips. The results showed that only 1 (0.7%) pregnant woman of the 150 tested positive for HIV. On the age group distribution of pregnant women tested for HIV in PHCC Jajere, it showed that 0 (0.0%) women aged 10–20 tested positive for HIV, 1 (0.7%) of those aged 21–30 were tested positive, 0 (0.0%) of those aged 31–40 were tested positive, and 0 (0.0%) of those aged 41–50 were tested positive for HIV. Whereas, the distribution of pregnant women tested positive for HIV in PHCC Jajere based on their locations showed that only 1 (0.7%) pregnant woman from Ganji was tested positive for HIV. It's therefore concluded that the sero-prevalence of HIV 1/2 in the study area is low, and thus, screening pregnant women for HIV/AIDS is recommended despite the low prevalence.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere
AU  - Ahmed Idriss Jajere
AU  - Isah Muhammad Liyo
AU  - Dembo Emmanuel Moses
Y1  - 2023/06/27
PY  - 2023
N1  - https://doi.org/10.11648/j.ijhpebs.20230901.16
DO  - 10.11648/j.ijhpebs.20230901.16
T2  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
JF  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
JO  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
SP  - 35
EP  - 38
PB  - Science Publishing Group
SN  - 2575-5765
UR  - https://doi.org/10.11648/j.ijhpebs.20230901.16
AB  - HIV/AIDS, also known as acquired immunodeficiency syndrome and human immunodeficiency virus infection, continue to be a global public health concern. A total of 150 pregnant patients at the PHCC clinic had their blood tested for the presence of HIV 1/2 antibodies. The DetermineTM HIV-1/2 in vitro diagnostic kit was used for the detection of human immunodeficiency virus antibodies (HIV). Using a pipette with arrows pointing in their direction and dropping the plasma samples onto the test strips, the reaction was allowed to occur for 15 minutes. Negative samples only display a color band in the control zone, while positive samples produce a red color band in both the test and control portions of the strips. The results showed that only 1 (0.7%) pregnant woman of the 150 tested positive for HIV. On the age group distribution of pregnant women tested for HIV in PHCC Jajere, it showed that 0 (0.0%) women aged 10–20 tested positive for HIV, 1 (0.7%) of those aged 21–30 were tested positive, 0 (0.0%) of those aged 31–40 were tested positive, and 0 (0.0%) of those aged 41–50 were tested positive for HIV. Whereas, the distribution of pregnant women tested positive for HIV in PHCC Jajere based on their locations showed that only 1 (0.7%) pregnant woman from Ganji was tested positive for HIV. It's therefore concluded that the sero-prevalence of HIV 1/2 in the study area is low, and thus, screening pregnant women for HIV/AIDS is recommended despite the low prevalence.
VL  - 9
IS  - 1
ER  -

Copy | Download

Author Information

Ahmed Idriss Jajere

Faculty of Science, Department of Biological Sciences, Federal University Gashua, Gashua, Nigeria
Isah Muhammad Liyo

Faculty of Science, Department of Biological Sciences, Federal University Gashua, Gashua, Nigeria
Dembo Emmanuel Moses

Faculty of Science, Department of Biological Sciences, Federal University Gashua, Gashua, Nigeria

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Ahmed Idriss Jajere, Isah Muhammad Liyo, Dembo Emmanuel Moses. (2023). Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. International Journal of HIV/AIDS Prevention, Education and Behavioural Science, 9(1), 35-38. https://doi.org/10.11648/j.ijhpebs.20230901.16

Copy | Download

ACS Style

Ahmed Idriss Jajere; Isah Muhammad Liyo; Dembo Emmanuel Moses. Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. Int. J. HIV/AIDS Prev. Educ. Behav. Sci. 2023, 9(1), 35-38. doi: 10.11648/j.ijhpebs.20230901.16

Copy | Download

AMA Style

Ahmed Idriss Jajere, Isah Muhammad Liyo, Dembo Emmanuel Moses. Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere. Int J HIV/AIDS Prev Educ Behav Sci. 2023;9(1):35-38. doi: 10.11648/j.ijhpebs.20230901.16

Copy | Download

@article{10.11648/j.ijhpebs.20230901.16,
  author = {Ahmed Idriss Jajere and Isah Muhammad Liyo and Dembo Emmanuel Moses},
  title = {Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere},
  journal = {International Journal of HIV/AIDS Prevention, Education and Behavioural Science},
  volume = {9},
  number = {1},
  pages = {35-38},
  doi = {10.11648/j.ijhpebs.20230901.16},
  url = {https://doi.org/10.11648/j.ijhpebs.20230901.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijhpebs.20230901.16},
  abstract = {HIV/AIDS, also known as acquired immunodeficiency syndrome and human immunodeficiency virus infection, continue to be a global public health concern. A total of 150 pregnant patients at the PHCC clinic had their blood tested for the presence of HIV 1/2 antibodies. The DetermineTM HIV-1/2 in vitro diagnostic kit was used for the detection of human immunodeficiency virus antibodies (HIV). Using a pipette with arrows pointing in their direction and dropping the plasma samples onto the test strips, the reaction was allowed to occur for 15 minutes. Negative samples only display a color band in the control zone, while positive samples produce a red color band in both the test and control portions of the strips. The results showed that only 1 (0.7%) pregnant woman of the 150 tested positive for HIV. On the age group distribution of pregnant women tested for HIV in PHCC Jajere, it showed that 0 (0.0%) women aged 10–20 tested positive for HIV, 1 (0.7%) of those aged 21–30 were tested positive, 0 (0.0%) of those aged 31–40 were tested positive, and 0 (0.0%) of those aged 41–50 were tested positive for HIV. Whereas, the distribution of pregnant women tested positive for HIV in PHCC Jajere based on their locations showed that only 1 (0.7%) pregnant woman from Ganji was tested positive for HIV. It's therefore concluded that the sero-prevalence of HIV 1/2 in the study area is low, and thus, screening pregnant women for HIV/AIDS is recommended despite the low prevalence.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Sero-Prevalence of Human Immunodeficiency Virus (HIV) Antibodies Among Pregnant Women Attending Primary Health Care Center (PHCC) Jajere
AU  - Ahmed Idriss Jajere
AU  - Isah Muhammad Liyo
AU  - Dembo Emmanuel Moses
Y1  - 2023/06/27
PY  - 2023
N1  - https://doi.org/10.11648/j.ijhpebs.20230901.16
DO  - 10.11648/j.ijhpebs.20230901.16
T2  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
JF  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
JO  - International Journal of HIV/AIDS Prevention, Education and Behavioural Science
SP  - 35
EP  - 38
PB  - Science Publishing Group
SN  - 2575-5765
UR  - https://doi.org/10.11648/j.ijhpebs.20230901.16
AB  - HIV/AIDS, also known as acquired immunodeficiency syndrome and human immunodeficiency virus infection, continue to be a global public health concern. A total of 150 pregnant patients at the PHCC clinic had their blood tested for the presence of HIV 1/2 antibodies. The DetermineTM HIV-1/2 in vitro diagnostic kit was used for the detection of human immunodeficiency virus antibodies (HIV). Using a pipette with arrows pointing in their direction and dropping the plasma samples onto the test strips, the reaction was allowed to occur for 15 minutes. Negative samples only display a color band in the control zone, while positive samples produce a red color band in both the test and control portions of the strips. The results showed that only 1 (0.7%) pregnant woman of the 150 tested positive for HIV. On the age group distribution of pregnant women tested for HIV in PHCC Jajere, it showed that 0 (0.0%) women aged 10–20 tested positive for HIV, 1 (0.7%) of those aged 21–30 were tested positive, 0 (0.0%) of those aged 31–40 were tested positive, and 0 (0.0%) of those aged 41–50 were tested positive for HIV. Whereas, the distribution of pregnant women tested positive for HIV in PHCC Jajere based on their locations showed that only 1 (0.7%) pregnant woman from Ganji was tested positive for HIV. It's therefore concluded that the sero-prevalence of HIV 1/2 in the study area is low, and thus, screening pregnant women for HIV/AIDS is recommended despite the low prevalence.
VL  - 9
IS  - 1
ER  -

Copy | Download